{"parse":{"title":"International Vaccine Institute","pageid":22613352,"revid":849068340,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"plainlinks metadata ambox ambox-content ambox-Advert\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x\" data-file-width=\"40\" data-file-height=\"40\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>contains content that is written like <a href=\"/wiki/Wikipedia:What_Wikipedia_is_not#Wikipedia_is_not_a_soapbox_or_means_of_promotion\" title=\"Wikipedia:What Wikipedia is not\">an advertisement</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=International_Vaccine_Institute&amp;action=edit\">improve it</a> by removing <a href=\"/wiki/Wikipedia:Spam\" title=\"Wikipedia:Spam\">promotional content</a> and inappropriate <a href=\"/wiki/Wikipedia:External_links\" title=\"Wikipedia:External links\">external links</a>, and by adding encyclopedic content written from a <a href=\"/wiki/Wikipedia:Neutral_point_of_view\" title=\"Wikipedia:Neutral point of view\">neutral point of view</a>.</span>  <small><i>(June 2018)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<table class=\"infobox vcard\" style=\"width:22em\"><caption class=\"fn org\">International Vaccine Institute</caption><tbody><tr><td colspan=\"2\" style=\"text-align:center\">\n<a href=\"/wiki/File:IVI_New_Logo_Big.jpg\" class=\"image\"><img alt=\"IVI New Logo Big.jpg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/cd/IVI_New_Logo_Big.jpg/220px-IVI_New_Logo_Big.jpg\" width=\"220\" height=\"70\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/c/cd/IVI_New_Logo_Big.jpg/330px-IVI_New_Logo_Big.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/cd/IVI_New_Logo_Big.jpg/440px-IVI_New_Logo_Big.jpg 2x\" data-file-width=\"940\" data-file-height=\"297\" /></a></td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\">Abbreviation</th><td class=\"nickname\">\nIVI</td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\">Formation</th><td class=\"note\">\nMay 29, 1997</td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\">Founder</th><td>\n<a href=\"/wiki/United_Nations_Development_Programme\" title=\"United Nations Development Programme\">United Nations Development Programme</a></td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\">Type</th><td>\n<a href=\"/wiki/International_organization\" title=\"International organization\">International_organization</a></td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\">Purpose</th><td>\nDiscover, develop, and deliver safe, effective, and affordable vaccines for global public health.</td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\">Headquarters</th><td>\n<a href=\"/wiki/Seoul\" title=\"Seoul\">Seoul</a>, <a href=\"/wiki/Republic_of_Korea\" class=\"mw-redirect\" title=\"Republic of Korea\">Republic of Korea</a></td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\"><div style=\"padding:0.1em 0;line-height:1.2em;\">Membership  </div></th><td>\n35 member states and the <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a></td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\"><div style=\"padding:0.1em 0;line-height:1.2em;\">Director General</div></th><td>\nJerome Kim, M.D.</td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\"><div style=\"padding:0.1em 0;line-height:1.2em;\">Budget  </div></th><td>\nUS$27 million(2017)<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup></td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\"><div style=\"padding:0.1em 0;line-height:1.2em;\">Staff  </div></th><td>\n123</td></tr><tr><th scope=\"row\" style=\"padding-right:0.6em;\">Website</th><td>\n<a rel=\"nofollow\" class=\"external text\" href=\"http://www.IVI.int\">www.IVI.int</a></td></tr></tbody></table>\n<p>The <b>International Vaccine Institute</b> (IVI) is an independent, nonprofit, international organization that was founded on the belief that the health of children in developing countries can be dramatically improved by the use of new and improved <a href=\"/wiki/Vaccines\" class=\"mw-redirect\" title=\"Vaccines\">vaccines</a>. Working in collaboration with the international scientific community, public health organizations, governments, and industry, IVI is involved in all areas of the vaccine spectrum \u2013 from new vaccine design in the laboratory to vaccine development and evaluation in the field to facilitating sustainable introduction of vaccines in countries where they are most needed.\n</p><p>Created initially as an initiative of the <a href=\"/wiki/United_Nations_Development_Programme\" title=\"United Nations Development Programme\">UN Development Programme</a> (UNDP), IVI began formal operations as an independent international organization in 1997 in <a href=\"/wiki/Seoul\" title=\"Seoul\">Seoul</a>, <a href=\"/wiki/Republic_of_Korea\" class=\"mw-redirect\" title=\"Republic of Korea\">Republic of Korea</a>. Currently, IVI has 35 countries and the <a href=\"/wiki/World_Health_Organization_(WHO)\" class=\"mw-redirect\" title=\"World Health Organization (WHO)\">World Health Organization (WHO)</a> as signatories to its Establishment Agreement. The Institute has a unique mandate to work exclusively on vaccine development and introduction specifically for people in developing countries, with a focus on neglected diseases affecting these regions.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Background\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Background</span></a></li>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Foundation\"><span class=\"tocnumber\">1.2</span> <span class=\"toctext\">Foundation</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Headquarters_building\"><span class=\"tocnumber\">1.3</span> <span class=\"toctext\">Headquarters building</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Previous_activities\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Previous activities</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Diseases_of_the_Most_Impoverished_(DOMI)_2000-2006\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Diseases of the Most Impoverished (DOMI) 2000-2006</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-7\"><a href=\"#DOMI_typhoid\"><span class=\"tocnumber\">2.1.1</span> <span class=\"toctext\">DOMI typhoid</span></a></li>\n<li class=\"toclevel-3 tocsection-8\"><a href=\"#DOMI_cholera\"><span class=\"tocnumber\">2.1.2</span> <span class=\"toctext\">DOMI cholera</span></a></li>\n<li class=\"toclevel-3 tocsection-9\"><a href=\"#DOMI_shigellosis\"><span class=\"tocnumber\">2.1.3</span> <span class=\"toctext\">DOMI shigellosis</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Rotavirus_Diarrhea_Program_1999-2010\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Rotavirus Diarrhea Program 1999-2010</span></a></li>\n<li class=\"toclevel-2 tocsection-11\"><a href=\"#Dengue_Vaccine_Programs_2002-2016\"><span class=\"tocnumber\">2.3</span> <span class=\"toctext\">Dengue Vaccine Programs 2002-2016</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-12\"><a href=\"#The_Pediatric_Dengue_Vaccine_Initiative_(PDVI)\"><span class=\"tocnumber\">2.3.1</span> <span class=\"toctext\">The Pediatric Dengue Vaccine Initiative (PDVI<b>)</b></span></a></li>\n<li class=\"toclevel-3 tocsection-13\"><a href=\"#Dengue_Vaccine_Initiative_(DVI)\"><span class=\"tocnumber\">2.3.2</span> <span class=\"toctext\">Dengue Vaccine Initiative (DVI)</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-2 tocsection-14\"><a href=\"#Signatory_Countries_of_the_IVI\"><span class=\"tocnumber\">2.4</span> <span class=\"toctext\">Signatory Countries of the IVI</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-15\"><a href=\"#Achievements\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Achievements</span></a></li>\n<li class=\"toclevel-1 tocsection-16\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-17\"><a href=\"#External_links\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Background\">Background</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=2\" title=\"Edit section: Background\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In 1992, Dr. Seung-Il Shin, then Senior Health Advisor for the <a href=\"/wiki/United_Nations_Development_Programme\" title=\"United Nations Development Programme\">United Nations Development Programme (UNDP)</a>, initiated a study to explore the feasibility of establishing an international institute devoted to vaccine research and development within the framework of the Children\u2019s Vaccine Initiative (CVI).<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> \n</p><p>Based on the results of Dr. Shin\u2019s feasibility study, in 1993 the UNDP adopted a formal proposal to establish the International Vaccine Institute (IVI). In 1994, following a call for proposals to host IVI in the Asia Pacific region, the UNDP and the Republic of Korea reached an agreement to host the center in Seoul. In 1995, UNDP opened an interim IVI office on the campus of Seoul National University and the Institute began its initial work and organizational development.\n</p>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:332px;\"><a href=\"/wiki/File:Establishment_Agreement_Signing.jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Establishment_Agreement_Signing.jpg/330px-Establishment_Agreement_Signing.jpg\" width=\"330\" height=\"198\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Establishment_Agreement_Signing.jpg/495px-Establishment_Agreement_Signing.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Establishment_Agreement_Signing.jpg/660px-Establishment_Agreement_Signing.jpg 2x\" data-file-width=\"1992\" data-file-height=\"1193\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:Establishment_Agreement_Signing.jpg\" class=\"internal\" title=\"Enlarge\"></a></div>Signing of the IVI Establishment Agreement</div></div></div>\n<h3><span class=\"mw-headline\" id=\"Foundation\">Foundation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=3\" title=\"Edit section: Foundation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>In 1995 and 1996, the UNDP and the South Korean government jointly developed the basic framework and Constitution of IVI. In order to establish IVI as an independent international organization, the UNDP and Korean government elected to establish the institute through an intergovernmental agreement of UN member states, as sanctioned in the <a href=\"/wiki/Vienna_Convention_on_the_Law_of_Treaties\" title=\"Vienna Convention on the Law of Treaties\">Vienna Convention on the Laws of Treaties of 1969</a>.\n</p><p>On October 28, 1996, the IVI Establishment Agreement opened for signatures at the <a href=\"/wiki/Headquarters_of_the_United_Nations\" title=\"Headquarters of the United Nations\">UN headquarters</a> in New York City. Representatives of <a href=\"/wiki/Bangladesh\" title=\"Bangladesh\">Bangladesh</a>, <a href=\"/wiki/Bhutan\" title=\"Bhutan\">Bhutan</a>, <a href=\"/wiki/Indonesia\" title=\"Indonesia\">Indonesia</a>, <a href=\"/wiki/Kazakhstan\" title=\"Kazakhstan\">Kazakhstan</a>, <a href=\"/wiki/Mongolia\" title=\"Mongolia\">Mongolia</a>, <a href=\"/wiki/Netherlands\" title=\"Netherlands\">the Netherlands</a>, <a href=\"/wiki/Panama\" title=\"Panama\">Panama</a>, <a href=\"/wiki/South_Korea\" title=\"South Korea\">Republic of Korea</a>, <a href=\"/wiki/Romania\" title=\"Romania\">Romania</a>, <a href=\"/wiki/Thailand\" title=\"Thailand\">Thailand</a>, <a href=\"/wiki/Vietnam\" title=\"Vietnam\">Vietnam</a>, <a href=\"/wiki/Uzbekistan\" title=\"Uzbekistan\">Uzbekistan</a>, and the <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">WHO</a> were the first to sign the agreement, followed shortly thereafter by <a href=\"/wiki/Senegal\" title=\"Senegal\">Senegal</a> and <a href=\"/wiki/Philippines\" title=\"Philippines\">the Philippines</a>.\n</p><p>In 1997 more countries followed, with <a href=\"/wiki/Brazil\" title=\"Brazil\">Brazil</a>, <a href=\"/wiki/China\" title=\"China\">China</a>, <a href=\"/wiki/Egypt\" title=\"Egypt\">Egypt</a>, <a href=\"/wiki/Israel\" title=\"Israel\">Israel</a>, <a href=\"/wiki/Jamaica\" title=\"Jamaica\">Jamaica</a>, <a href=\"/wiki/Kyrgyzstan\" title=\"Kyrgyzstan\">Kyrgyzstan</a>, <a href=\"/wiki/Myanmar\" title=\"Myanmar\">Myanmar</a>, <a href=\"/wiki/Nepal\" title=\"Nepal\">Nepal</a>, <a href=\"/wiki/Pakistan\" title=\"Pakistan\">Pakistan</a>, <a href=\"/wiki/Papua_New_Guinea\" title=\"Papua New Guinea\">Papua New Guinea</a>, <a href=\"/wiki/Peru\" title=\"Peru\">Peru</a>, <a href=\"/wiki/Sri_Lanka\" title=\"Sri Lanka\">Sri Lanka</a>, <a href=\"/wiki/Sweden\" title=\"Sweden\">Sweden</a>, <a href=\"/wiki/Tajikistan\" title=\"Tajikistan\">Tajikistan</a>, and Turkey signing the Agreement.<sup id=\"cite_ref-:1_3-0\" class=\"reference\"><a href=\"#cite_note-:1-3\">&#91;3&#93;</a></sup>\n</p><p>On May 29, 1997, The IVI Establishment Agreement entered into force following the submission of instruments of ratification by South Korea, Sweden, and Uzbekistan. The IVI Establishment Agreement entered the <a href=\"/wiki/Treaty_series#United_Nations\" title=\"Treaty series\">United Nations Depository of Treaties</a> under Chapter IX. HEALTH, section 3.<sup id=\"cite_ref-:1_3-1\" class=\"reference\"><a href=\"#cite_note-:1-3\">&#91;3&#93;</a></sup>\n</p><p>On September 24, 1998 the IVI Headquarters Agreement was signed at a formal ceremony at <a href=\"/wiki/United_Nations_Development_Programme\" title=\"United Nations Development Programme\">UNDP headquarters</a> by South Korea\u2019s Minister of Foreign Affairs and Trade, Hon. <a href=\"/wiki/Hong_Soon-young\" title=\"Hong Soon-young\">Hong Soon-Young</a> and IVI Board Chairman, <a href=\"/wiki/Barry_Bloom\" title=\"Barry Bloom\">Dr. Barry Bloom</a>. The Headquarters Agreement established IVI as a legal entity with diplomatic immunity in South Korea,, becoming the first international organization to be headquartered in South Korea. In accordance with IVI\u2019s independent status, the Institute formally separated from the UNDP in 1998. \n</p>\n<div class=\"thumb tright\"><div class=\"thumbinner\" style=\"width:292px;\"><a href=\"/wiki/File:IVI_Building_(1).jpg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/8b/IVI_Building_%281%29.jpg/290px-IVI_Building_%281%29.jpg\" width=\"290\" height=\"258\" class=\"thumbimage\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/8/8b/IVI_Building_%281%29.jpg/435px-IVI_Building_%281%29.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/8b/IVI_Building_%281%29.jpg/580px-IVI_Building_%281%29.jpg 2x\" data-file-width=\"2340\" data-file-height=\"2080\" /></a>  <div class=\"thumbcaption\"><div class=\"magnify\"><a href=\"/wiki/File:IVI_Building_(1).jpg\" class=\"internal\" title=\"Enlarge\"></a></div>IVI Headquarters</div></div></div>\n<h3><span class=\"mw-headline\" id=\"Headquarters_building\">Headquarters building</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=4\" title=\"Edit section: Headquarters building\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The IVI headquarters building, located in <a href=\"/wiki/Seoul_National_University\" title=\"Seoul National University\">Seoul National University</a>\u2019s Research Park in <a href=\"/wiki/Seoul\" title=\"Seoul\">Seoul</a>, <a href=\"/wiki/South_Korea\" title=\"South Korea\">South Korea</a>, was designed by a consortium consisting of <a href=\"/wiki/Samoo_Architects_%26_Engineers\" title=\"Samoo Architects &amp; Engineers\">Samwoo Architects</a> of South Korea and <a rel=\"nofollow\" class=\"external text\" href=\"https://www.payette.com/\">Payette Associates</a> of Boston, USA. Construction began in 1998 and was completed in 2003. The building houses laboratories, animal facilities, offices, an auditorium, and a library. A separate 1,300m\u00b2 pilot plant facility, intended for the production of test lots of vaccines for training and evaluation purposes, was constructed but never completed due to a lack of funding.\n</p>\n<h2><span class=\"mw-headline\" id=\"Previous_activities\">Previous activities</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=5\" title=\"Edit section: Previous activities\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span id=\"Diseases_of_the_Most_Impoverished_.28DOMI.29_2000-2006\"></span><span class=\"mw-headline\" id=\"Diseases_of_the_Most_Impoverished_(DOMI)_2000-2006\">Diseases of the Most Impoverished (DOMI) 2000-2006</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=6\" title=\"Edit section: Diseases of the Most Impoverished (DOMI) 2000-2006\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>IVI\u2019s first major initiative, Diseases of the Most Impoverished (DOMI) was a program of research and technical assistance to accelerate the introduction of new vaccines against <a href=\"/wiki/Typhoid_fever\" title=\"Typhoid fever\">typhoid fever</a>, <a href=\"/wiki/Cholera\" title=\"Cholera\">cholera</a>, and <a href=\"/wiki/Shigellosis\" title=\"Shigellosis\">shigellosis</a> into public health programs for the poor in developing countries. From 2000 to 2006, IVI\u2019s DOMI program carried out vaccination campaigns, disease surveillance, and research studies in <a href=\"/wiki/Bangladesh\" title=\"Bangladesh\">Bangladesh</a>, <a href=\"/wiki/China\" title=\"China\">China</a>, <a href=\"/wiki/India\" title=\"India\">India</a>, <a href=\"/wiki/Indonesia\" title=\"Indonesia\">Indonesia</a>, <a href=\"/wiki/Mozambique\" title=\"Mozambique\">Mozambique</a>, <a href=\"/wiki/Pakistan\" title=\"Pakistan\">Pakistan</a>, <a href=\"/wiki/Thailand\" title=\"Thailand\">Thailand</a>, and <a href=\"/wiki/Vietnam\" title=\"Vietnam\">Vietnam</a>. &#160;At the conclusion of the DOMI program, IVI synthesized the diverse epidemiological, clinical, economic, and behavioral findings of these studies in order to facilitate informed decision-making by policymakers at the national level on the use of vaccines against the diseases targeted by DOMI. The <a href=\"/wiki/Bill_%26_Melinda_Gates_Foundation\" title=\"Bill &amp; Melinda Gates Foundation\">Bill and Melinda Gates Foundation</a> was the primary funder of the DOMI program with a US$40 million contribution.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"DOMI_typhoid\">DOMI typhoid</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=7\" title=\"Edit section: DOMI typhoid\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>The DOMI Typhoid program was initiated to address the barriers of access to <a href=\"/wiki/Typhoid_vaccine\" title=\"Typhoid vaccine\">typhoid vaccines</a> in the developing world and to accelerate the introduction of modern typhoid vaccines in countries where they were needed. DOMI Typhoid utilized the Vi-<a href=\"/wiki/Polysaccharide\" title=\"Polysaccharide\">Polysaccharide</a> (Vi-PS) vaccine because it is easily and inexpensively produced by manufacturers in developing countries, it is given in a single dose, and it is relatively thermostable. DOMI Typhoid operated in five study sites: <a href=\"/wiki/Hechi\" title=\"Hechi\">Heichi</a>, China; <a href=\"/wiki/Kolkata\" title=\"Kolkata\">Kolkata</a>, India; <a href=\"/wiki/North_Jakarta\" title=\"North Jakarta\">North Jakarta</a>, Indonesia; <a href=\"/wiki/Karachi\" title=\"Karachi\">Karachi</a>, Pakistan; and <a href=\"/wiki/Hu%E1%BA%BF\" title=\"Hu\u1ebf\">Hue</a>, Vietnam. From these sites, IVI experts conducted disease surveillance, disease burden studies, cost-of-illness studies, socio-behavioral studies, and vaccine demonstration projects. IVI presented the accumulated evidence from DOMI Typhoid in case studies to officials in each host country. As a result, policymakers in Pakistan, Indonesia, and Vietnam agreed to introduce school-based typhoid vaccination campaigns on a pilot basis. Results from China uncovered a previously unknown growing incidence rate of <a href=\"/wiki/Paratyphoid_fever\" title=\"Paratyphoid fever\">paratyphoid A</a> infections in China\u2019s <a href=\"/wiki/Guangxi\" title=\"Guangxi\">Guangxi province</a>, which led to IVI launching its Paratyphoid in China project.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"DOMI_cholera\">DOMI cholera</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=8\" title=\"Edit section: DOMI cholera\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>The DOMI Cholera program sought to develop and accelerate the use of an affordable <a href=\"/wiki/Cholera_vaccine\" title=\"Cholera vaccine\">cholera vaccine</a> in <a href=\"/wiki/Cholera\" title=\"Cholera\">cholera</a>-endemic countries. DOMI Cholera operated from five study sites: <a href=\"/wiki/Matlab_(Bangladesh)\" title=\"Matlab (Bangladesh)\">Matlab</a>, Bangladesh; <a href=\"/wiki/North_Jakarta\" title=\"North Jakarta\">North Jakarta</a>, Indonesia; <a href=\"/wiki/Kolkata\" title=\"Kolkata\">Kolkata</a>, India; <a href=\"/wiki/Beira,_Mozambique\" title=\"Beira, Mozambique\">Beira</a>, Mozambique; and <a href=\"/wiki/Hu%E1%BA%BF\" title=\"Hu\u1ebf\">Hue</a>, Vietnam. From these sites, IVI conducted disease burden, economic, and socio-behavioral studies and cholera vaccination campaigns. The studies found a high demand for cholera vaccine and high incidence rates (3-9/1,000) in children 5 years old and younger. IVI\u2019s vaccination campaign in Beira saw more than 44,000 children and adults receive the internationally-licensed Dukoral vaccine. In Kolkata, IVI vaccinated more than 67,000 children and adults using an oral cholera vaccine produced by Vietnam\u2019s <a rel=\"nofollow\" class=\"external text\" href=\"http://www.vabiotech.com.vn/?lang=en\">VaBiotech.</a> At the onset of DOMI Cholera, the only internationally licensed cholera vaccine available was Dukoral, but at $90 for the two-dose series, this vaccine was too expensive for public use in many of the poorest developing countries. VaBiotech\u2019s cholera vaccine, originally developed by Vietnam\u2019s <a rel=\"nofollow\" class=\"external text\" href=\"http://nihe.org.vn/en/home-c10902.htm\">National Institute of Health and Epidemiology</a> following a technology transfer from the <a href=\"/wiki/University_of_Gothenburg\" title=\"University of Gothenburg\">University of Gothenburg</a> in <a href=\"/wiki/Sweden\" title=\"Sweden\">Sweden</a>, was not licensed for international use but showed great promise as a low-cost vaccine for the developing world. As a result, the <a href=\"/wiki/Bill_%26_Melinda_Gates_Foundation\" title=\"Bill &amp; Melinda Gates Foundation\">Gates Foundation</a> provided IVI with additional funding to establish the Cholera Vaccine Initiative (CVI) with the goal of reformulating the VaBiotech vaccine for international use. \n</p>\n<h4><span class=\"mw-headline\" id=\"DOMI_shigellosis\">DOMI shigellosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=9\" title=\"Edit section: DOMI shigellosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>IVI established the DOMI <a href=\"/wiki/Shigellosis\" title=\"Shigellosis\">Shigellosis</a> program with the ultimate goal of accelerating the development and introduction of a safe and protective shigella vaccine to control epidemic and endemic disease. Between 2000 and 2004, the DOMI Shigella program ran disease surveillance sites in 6 locations across Southeast Asia: <a href=\"/wiki/Dhaka\" title=\"Dhaka\">Dhaka</a>, Bangladesh; <a href=\"/wiki/Hebei\" title=\"Hebei\">Hebei</a>, China; <a href=\"/wiki/Karachi\" title=\"Karachi\">Karachi</a>, Pakistan and neighboring villages; <a href=\"/wiki/North_Jakarta\" title=\"North Jakarta\">North Jakarta</a>, Indonesia; <a href=\"/wiki/Nha_Trang\" title=\"Nha Trang\">Nha Trang</a>, Vietnam; and <a href=\"/wiki/Saraburi_Province\" title=\"Saraburi Province\">Saraburi Province</a>, Thailand. The program enhanced understanding of what an effective shigella vaccine will need and established an accurate disease burden in the countries where it operated. The program first evaluated an oral shigella vaccine (SC602) in Bangladesh, but it failed to elicit an immune response. The high disease burden, serotype diversity, and high levels AMR discovered at IVI's surveillance sites underscored the need for a vaccine that protects against all common strains of the disease. As a result, IVI\u2019s Division of Laboratory Sciences initiated a multiyear program to sequence the Shigella genome and identify common proteins in different Shigella species that could be used to develop a vaccine against all common strains of the disease.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Rotavirus_Diarrhea_Program_1999-2010\">Rotavirus Diarrhea Program 1999-2010</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=10\" title=\"Edit section: Rotavirus Diarrhea Program 1999-2010\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>IVI initiated the Rotavirus Diarrhea Program to provide policymakers in developing countries with the disease burden evidence and economic data needed to ensure the inclusion of <a href=\"/wiki/Rotavirus_vaccine\" title=\"Rotavirus vaccine\">rotavirus vaccines</a> in their <a href=\"/wiki/Vaccination_schedule\" title=\"Vaccination schedule\">national immunization programs</a>. Running from 1999 to 2010, the program conducted disease surveillance and economic studies in <a href=\"/wiki/Cambodia\" title=\"Cambodia\">Cambodia</a>, <a href=\"/wiki/China\" title=\"China\">China</a>, <a href=\"/wiki/India\" title=\"India\">India</a>, <a href=\"/wiki/Indonesia\" title=\"Indonesia\">Indonesia</a>, <a href=\"/wiki/Laos\" title=\"Laos\">Laos</a>, <a href=\"/wiki/Mongolia\" title=\"Mongolia\">Mongolia</a>, <a href=\"/wiki/South_Korea\" title=\"South Korea\">South Korea</a>, <a href=\"/wiki/Sri_Lanka\" title=\"Sri Lanka\">Sri Lanka</a>, and <a href=\"/wiki/Vietnam\" title=\"Vietnam\">Vietnam</a>. In 2007, in collaboration with Vietnam\u2019s National Institute of Hygiene and Epidemiology (NIHE), IVI conducted a Phase II trial of <a href=\"/wiki/GlaxoSmithKline\" title=\"GlaxoSmithKline\">GSK\u2019s</a> RotaRix rotavirus vaccine in <a href=\"/wiki/Kh%C3%A1nh_H%C3%B2a_Province\" title=\"Kh\u00e1nh H\u00f2a Province\">Khanh Hoa</a>, Vietnam. &#160;In 2009, in collaboration with NIHE, <a href=\"/wiki/PATH_(global_health_organization)\" title=\"PATH (global health organization)\">PATH</a>, and <a href=\"/wiki/Merck_%26_Co.\" title=\"Merck &amp; Co.\">Merck</a>, IVI completed a phase III trial of Merck\u2019s RotaTeq rotavirus vaccine in <a href=\"/wiki/Nha_Trang\" title=\"Nha Trang\">Nha Trang</a> Vietnam, where it vaccinated 900 infants.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>&#160; \n</p>\n<h3><span class=\"mw-headline\" id=\"Dengue_Vaccine_Programs_2002-2016\">Dengue Vaccine Programs 2002-2016</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=11\" title=\"Edit section: Dengue Vaccine Programs 2002-2016\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<h4><span id=\"The_Pediatric_Dengue_Vaccine_Initiative_.28PDVI.29\"></span><span class=\"mw-headline\" id=\"The_Pediatric_Dengue_Vaccine_Initiative_(PDVI)\">The Pediatric Dengue Vaccine Initiative (PDVI<b>)</b></span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=12\" title=\"Edit section: The Pediatric Dengue Vaccine Initiative (PDVI)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>The Pediatric <a href=\"/wiki/Dengue_fever\" title=\"Dengue fever\">Dengue</a> Vaccine Initiative was a product development partnership launched by IVI to accelerate the introduction of safe and effective <a href=\"/wiki/Dengue_vaccine\" title=\"Dengue vaccine\">dengue vaccine</a>s for children in dengue-endemic countries. From 2002 to 2010, PDVI operated in <a href=\"/wiki/Brazil\" title=\"Brazil\">Brazil</a>, <a href=\"/wiki/Cambodia\" title=\"Cambodia\">Cambodia</a>, <a href=\"/wiki/Colombia\" title=\"Colombia\">Colombia</a>, <a href=\"/wiki/India\" title=\"India\">India</a>, <a href=\"/wiki/Indonesia\" title=\"Indonesia\">Indonesia</a>, <a href=\"/wiki/Laos\" title=\"Laos\">Laos</a>, <a href=\"/wiki/Malaysia\" title=\"Malaysia\">Malaysia</a>, <a href=\"/wiki/Mexico\" title=\"Mexico\">Mexico</a>, <a href=\"/wiki/Myanmar\" title=\"Myanmar\">Myanmar</a>, <a href=\"/wiki/Nicaragua\" title=\"Nicaragua\">Nicaragua</a>, <a href=\"/wiki/Sri_Lanka\" title=\"Sri Lanka\">Sri Lanka</a>, <a href=\"/wiki/Thailand\" title=\"Thailand\">Thailand</a> and <a href=\"/wiki/Vietnam\" title=\"Vietnam\">Vietnam</a>. PDVI made many contributions to dengue vaccine development, including:\n</p>\n<ul><li>Development of a dengue vaccine partnership and global research network to develop, evaluate, and introduce dengue vaccines. Working with Brazil\u2019s <a href=\"/wiki/Instituto_Butantan\" title=\"Instituto Butantan\">Butantan Institute</a>, the <a href=\"/wiki/National_Institutes_of_Health\" title=\"National Institutes of Health\">U.S. National Institute of Health</a>, and <a href=\"/wiki/Sanofi_Pasteur\" title=\"Sanofi Pasteur\">Sanofi Pasteur</a>, PDVI provided technical advice and support for the efficacy and clinical trials of their respective dengue vaccine candidates and established a consortium of field sites in dengue-endemic countries across Asia and the Americas.</li>\n<li>Establishment of two regional Dengue Prevention Boards in the Asia-Pacific region and the Americas to disseminate information and make recommendations regarding the control of dengue through immunization.</li>\n<li>Collaboration with the <a href=\"/wiki/Centers_for_Disease_Control_and_Prevention\" title=\"Centers for Disease Control and Prevention\">U.S. Centers for Disease Control and Prevention</a> to develop a free user-friendly software, <a rel=\"nofollow\" class=\"external text\" href=\"http://www.denguevaccine.org/resource-search/?types%5B%5D=2\">DenguEcon</a>, which can be used by policymakers to determine the economic impact of dengue.</li></ul>\n<p>In 2010, PDVI transitioned into the Dengue Vaccine Initiative (DVI).<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup>\n</p>\n<h4><span id=\"Dengue_Vaccine_Initiative_.28DVI.29\"></span><span class=\"mw-headline\" id=\"Dengue_Vaccine_Initiative_(DVI)\">Dengue Vaccine Initiative (DVI)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=13\" title=\"Edit section: Dengue Vaccine Initiative (DVI)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>The successor to PDVI, the Dengue Vaccine Initiative was an IVI-led consortium with the <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a>, <a href=\"/wiki/Sabin_Vaccine_Institute\" title=\"Sabin Vaccine Institute\">the Sabin Vaccine Institute</a>, the Initiative for Vaccine Research (IVR), and the <a rel=\"nofollow\" class=\"external text\" href=\"http://ivac.jhu.edu/\">International Vaccine Access Center (IVAC)</a> at <a href=\"/wiki/Johns_Hopkins_University\" title=\"Johns Hopkins University\">Johns Hopkins University</a>. DVI continued the work of PDVI and focused on laying the groundwork for dengue vaccine decision-making and vaccine introduction in endemic areas. Each consortium member was responsible for a specific component: WHO \u2013 information and guidance documents, and regulatory training activities; Johns Hopkins \u2013 dengue vaccine financing and strategic demand forecasting; and Sabin \u2013 communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in <a href=\"/wiki/Brazil\" title=\"Brazil\">Brazil</a>, <a href=\"/wiki/Burkina_Faso\" title=\"Burkina Faso\">Burkina Faso</a>, <a href=\"/wiki/Cambodia\" title=\"Cambodia\">Cambodia</a>, <a href=\"/wiki/Colombia\" title=\"Colombia\">Colombia</a>, <a href=\"/wiki/Gabon\" title=\"Gabon\">Gabon</a>, <a href=\"/wiki/India\" title=\"India\">India</a>, <a href=\"/wiki/Kenya\" title=\"Kenya\">Kenya</a>, <a href=\"/wiki/Thailand\" title=\"Thailand\">Thailand</a>, and <a href=\"/wiki/Vietnam\" title=\"Vietnam\">Vietnam</a>. From 2013-2015, with funding from <a href=\"/wiki/Germany\" title=\"Germany\">Germany</a>\u2019s <a href=\"/wiki/Federal_Ministry_of_Education_and_Research_(Germany)\" title=\"Federal Ministry of Education and Research (Germany)\">Federal Ministry of Education &amp; Research (BMBF)</a>, IVI continued support for preclinical development of dengue vaccines by Brazil\u2019s <a href=\"/wiki/Instituto_Butantan\" title=\"Instituto Butantan\">Butantan Institute</a> and Vietnam\u2019s VaBiotech. After the 2016 licensure of <a href=\"/wiki/Sanofi\" title=\"Sanofi\">Sanofi Pasteur\u2019s</a> Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to a new project, the Global Dengue &amp; <a href=\"/wiki/Aedes\" title=\"Aedes\">Aedes</a>-Transmitted Disease Consortium (GDAC).<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Signatory_Countries_of_the_IVI\">Signatory Countries of the IVI</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=14\" title=\"Edit section: Signatory Countries of the IVI\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>As of January 2011, IVI includes 40 countries and the <b>World Health Organization (WHO)</b> as signatories to its Establishment Agreement. To be more specific, there are 33 signatory countries, which are the states that express their consent to be bound by a treaty by signing the treaty without the need for ratification, acceptance of approval. These states may definitively sign a treaty only when the treaty so permits. In addition, there are 16 parties which involve <b>Liberia, Republic of Korea, Brazil, Mongolia, China, Sri Lanka, Ecuador, Sweden, Netherlands, Oman, Pakistan, Uzbekistan, Vietnam, Peru, Philippines</b>, and the <b>World Health Organization (WHO)</b>. A major difference between a signatory and a party is that a party to a treaty is a state or other entity with treaty-making capacity that has expressed its consent to be bound by that treaty by an act of ratification, acceptance, approval or accession etc. where that treaty has entered into force for that particular State.\n</p><p>In short, in addition to the <a href=\"/wiki/World_Health_Organization_(WHO)\" class=\"mw-redirect\" title=\"World Health Organization (WHO)\">World Health Organization (WHO)</a>, 40 countries include <a href=\"/wiki/Bangladesh\" title=\"Bangladesh\">Bangladesh</a>, <a href=\"/wiki/Liberia\" title=\"Liberia\">Liberia</a>**, <a href=\"/wiki/Republic_of_Korea\" class=\"mw-redirect\" title=\"Republic of Korea\">Republic of Korea</a>**, <a href=\"/wiki/Bhutan\" title=\"Bhutan\">Bhutan</a>, <a href=\"/wiki/Malta\" title=\"Malta\">Malta</a>, <a href=\"/wiki/Romania\" title=\"Romania\">Romania</a>, <a href=\"/wiki/Brazil\" title=\"Brazil\">Brazil</a>**, <a href=\"/wiki/Mongolia\" title=\"Mongolia\">Mongolia</a>**, <a href=\"/wiki/Senegal\" title=\"Senegal\">Senegal</a>, <a href=\"/wiki/China\" title=\"China\">China</a>**, <a href=\"/wiki/Myanmar\" title=\"Myanmar\">Myanmar</a>, <a href=\"/wiki/Sri_Lanka\" title=\"Sri Lanka\">Sri Lanka</a>**, <a href=\"/wiki/Ecuador\" title=\"Ecuador\">Ecuador</a>**, <a href=\"/wiki/Nepal\" title=\"Nepal\">Nepal</a>, <a href=\"/wiki/Sweden\" title=\"Sweden\">Sweden</a>**, <a href=\"/wiki/Egypt\" title=\"Egypt\">Egypt</a>, <a href=\"/wiki/Netherlands\" title=\"Netherlands\">Netherlands</a>**, <a href=\"/wiki/Tajikistan\" title=\"Tajikistan\">Tajikistan</a>, <a href=\"/wiki/Indonesia\" title=\"Indonesia\">Indonesia</a>, <a href=\"/wiki/Oman\" title=\"Oman\">Oman</a>**, <a href=\"/wiki/Thailand\" title=\"Thailand\">Thailand</a>, <a href=\"/wiki/Israel\" title=\"Israel\">Israel</a>, <a href=\"/wiki/Pakistan\" title=\"Pakistan\">Pakistan</a>**, <a href=\"/wiki/Turkey\" title=\"Turkey\">Turkey</a>, <a href=\"/wiki/Jamaica\" title=\"Jamaica\">Jamaica</a>, <a href=\"/wiki/Panama\" title=\"Panama\">Panama</a>, <a href=\"/wiki/Uzbekistan\" title=\"Uzbekistan\">Uzbekistan</a>**, <a href=\"/wiki/Kazakhstan\" title=\"Kazakhstan\">Kazakhstan</a>, <a href=\"/wiki/Papua_New_Guinea\" title=\"Papua New Guinea\">Papua New Guinea</a>, <a href=\"/wiki/Vietnam\" title=\"Vietnam\">Vietnam</a>**, <a href=\"/wiki/Kyrgyzstan\" title=\"Kyrgyzstan\">Kyrgyzstan</a>, <a href=\"/wiki/Peru\" title=\"Peru\">Peru</a>**, <a href=\"/wiki/Lebanon\" title=\"Lebanon\">Lebanon</a>, <a href=\"/wiki/Philippines\" title=\"Philippines\">Philippines</a>**, <a href=\"/wiki/Cote_d%27Ivoire\" class=\"mw-redirect\" title=\"Cote d&#39;Ivoire\">Cote d'Ivoire</a>, <a href=\"/wiki/India\" title=\"India\">India</a>, <a href=\"/wiki/Kuwait\" title=\"Kuwait\">Kuwait</a>, <a href=\"/wiki/Slovakia\" title=\"Slovakia\">Slovakia</a>, <a href=\"/wiki/Spain\" title=\"Spain\">Spain</a>, and <a href=\"/wiki/United_Arab_Emirates\" title=\"United Arab Emirates\">United Arab Emirates</a>.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Achievements\">Achievements</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=15\" title=\"Edit section: Achievements\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>IVI has developed 3 new or improved vaccines: reformulated oral <a href=\"/wiki/Cholera\" title=\"Cholera\">cholera</a> vaccine, typhoid Vi <a href=\"/wiki/Polysaccharide\" title=\"Polysaccharide\">polysaccharide</a> vaccine, and typhoid Vi <a href=\"/wiki/Conjugate_vaccine\" title=\"Conjugate vaccine\">conjugate vaccine</a>.</li>\n<li><a href=\"/wiki/Shanchol\" class=\"mw-redirect\" title=\"Shanchol\">Shanchol</a>\u2122, the oral cholera vaccine developed and licensed under guidance by IVI, was prequalified by WHO in September 2011.</li>\n<li>IVI has completed a global investment case for cholera vaccines, the first report to systematically provide detailed estimates of the disease burden of cholera and the global cost-effectiveness of cholera vaccination.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup></li>\n<li>IVI and the National Institute of Cholera and Enteric Diseases (NICED) jointly established a state-of-the-art immune-monitoring laboratory in <a href=\"/wiki/Kolkata\" title=\"Kolkata\">Kolkata, India</a>.</li>\n<li>IVI was the first to identify that <a href=\"/wiki/Japanese_Encephalitis\" class=\"mw-redirect\" title=\"Japanese Encephalitis\">Japanese encephalitis</a> is a major problem in <a href=\"/wiki/Bali\" title=\"Bali\">Bali, Indonesia</a>.</li>\n<li>IVI scientists developed the first <a href=\"/wiki/Animal_model\" class=\"mw-redirect\" title=\"Animal model\">animal model</a> of <i>Shigella</i> colitis for use in developing a <a href=\"/wiki/Shigella\" title=\"Shigella\">Shigella</a> vaccine.</li>\n<li>Since 2000, IVI has hosted an annual International Advanced Course on Vaccinology for the <a href=\"/wiki/Asia-Pacific\" title=\"Asia-Pacific\">Asia-Pacific</a> Region to build country capacity in vaccine-related research.</li>\n<li>IVI demonstrated for the first time that killed oral cholera vaccine is effective in populations with high rates of <a href=\"/wiki/HIV\" title=\"HIV\">HIV</a>/AIDS(Mozambique).<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=16\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.ivi.int/wp-content/uploads/2017/03/IVIAnnualReport2017_ENG.pdf\">http://www.ivi.int/wp-content/uploads/2017/03/IVIAnnualReport2017_ENG.pdf</a></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.crunchbase.com/person/seung-il-shin\">\"Seung Il Shin - Founder &amp; Board Director @ Global Solutions for Infectious Diseases | Crunchbase\"</a>. <i>Crunchbase</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2018-06-12</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Crunchbase&amp;rft.atitle=Seung+Il+Shin+-+Founder+%26amp%3B+Board+Director+%40+Global+Solutions+for+Infectious+Diseases+%7C+Crunchbase&amp;rft_id=https%3A%2F%2Fwww.crunchbase.com%2Fperson%2Fseung-il-shin&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInternational+Vaccine+Institute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:1-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:1_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:1_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://treaties.un.org/Pages/ViewDetails.aspx?src=TREATY&amp;mtdsg_no=IX-3&amp;chapter=9&amp;clang=_en\">\"United Nations Treaty Collection\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2018-06-12</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=United+Nations+Treaty+Collection&amp;rft_id=https%3A%2F%2Ftreaties.un.org%2FPages%2FViewDetails.aspx%3Fsrc%3DTREATY%26mtdsg_no%3DIX-3%26chapter%3D9%26clang%3D_en&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInternational+Vaccine+Institute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\"><i>IVI Annual Report 2003-2004</i>. IVI Library, Seoul, South Korea: International Vaccine Institute. 2005. pp.&#160;1\u20133.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=IVI+Annual+Report+2003-2004&amp;rft.place=IVI+Library%2C+Seoul%2C+South+Korea&amp;rft.pages=1-3&amp;rft.pub=International+Vaccine+Institute&amp;rft.date=2005&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInternational+Vaccine+Institute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\"><i>IVI Annual Report 2006-2007</i>. IVI Library, Seoul, South Korea.: International Vaccine institute. 2008. p.&#160;7.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=IVI+Annual+Report+2006-2007&amp;rft.place=IVI+Library%2C+Seoul%2C+South+Korea.&amp;rft.pages=7&amp;rft.pub=International+Vaccine+institute&amp;rft.date=2008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInternational+Vaccine+Institute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\"><i>IVI Annual Report 2006-2007</i>. IVI Library, Seoul, South Korea: International Vaccine Institute. 2008. pp.&#160;10\u201313.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=IVI+Annual+Report+2006-2007&amp;rft.place=IVI+Library%2C+Seoul%2C+South+Korea&amp;rft.pages=10-13&amp;rft.pub=International+Vaccine+Institute&amp;rft.date=2008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInternational+Vaccine+Institute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\"><i>IVI Annual Report 2006-2007</i>. IVI Library, Seoul, South Korea: International Vaccine Institute. 2008. pp.&#160;22\u201324.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=IVI+Annual+Report+2006-2007&amp;rft.place=IVI+Library%2C+Seoul%2C+South+Korea&amp;rft.pages=22-24&amp;rft.pub=International+Vaccine+Institute&amp;rft.date=2008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInternational+Vaccine+Institute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\"><i>IVI Annual Report 2009</i>. IVI Library, Seoul, South Korea: International Vaccine Institute. 2010. pp.&#160;24\u201326.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=IVI+Annual+Report+2009&amp;rft.place=IVI+Library%2C+Seoul%2C+South+Korea&amp;rft.pages=24-26&amp;rft.pub=International+Vaccine+Institute&amp;rft.date=2010&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInternational+Vaccine+Institute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\"><i>IVI Annual Report 2010</i>. IVI Library, Seoul, South Korea: International Vaccine Institute. 2011. pp.&#160;22\u201326.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=IVI+Annual+Report+2010&amp;rft.place=IVI+Library%2C+Seoul%2C+South+Korea&amp;rft.pages=22-26&amp;rft.pub=International+Vaccine+Institute&amp;rft.date=2011&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInternational+Vaccine+Institute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ivi.int/wp-content/uploads/kboard_attached/11/201610/IVI%20Annual%20Report%202015.pdf\">\"IVI 2015 Annual Report\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>www.ivi.int</i><span class=\"reference-accessdate\">. Retrieved 6/15/2018</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.ivi.int&amp;rft.atitle=IVI+2015+Annual+Report&amp;rft_id=http%3A%2F%2Fwww.ivi.int%2Fwp-content%2Fuploads%2Fkboard_attached%2F11%2F201610%2FIVI%2520Annual%2520Report%25202015.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInternational+Vaccine+Institute\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;access-date=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ivi.int/about_us/signatory_countries.html\">Governance. 'Signatory Countries.'</a></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\">IVI publication. 'An Investment Case for the Accelerated Introduction of Oral Cholera Vaccines.' March 2012, accessible at <a rel=\"nofollow\" class=\"external free\" href=\"http://www.ivi.int/publication/IVI_Global_cholera_case.pdf\">http://www.ivi.int/publication/IVI_Global_cholera_case.pdf</a>.</span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\">Globe Network. 'Fondation M\u00e9rieux Report of the Meeting on Focus on Neglected Tropical Infectious Diseases: Integrating Vaccines into Global Cholera Control Efforts.' April 2009, accessible at <a rel=\"nofollow\" class=\"external free\" href=\"http://www.globe-network.org/documents/conferences/2009/Focus-on-neglected-tropical-infectious-diseases-Integrating-vaccines-into-global-cholera-control-efforts/Scientific-report.pdf\">http://www.globe-network.org/documents/conferences/2009/Focus-on-neglected-tropical-infectious-diseases-Integrating-vaccines-into-global-cholera-control-efforts/Scientific-report.pdf</a></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=International_Vaccine_Institute&amp;action=edit&amp;section=17\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ivi.int/\">International Vaccine Institute</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.denguevaccines.org\">Dengue Vaccine Initiative (DVI)</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://viva.ivi.int/\">Vi-based Vaccines for Asia Initiative (VIVA)</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.who.int/\">World Health Organization (WHO)</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.biomedcentral.com/inst/124916\">IVI at BioMed Central</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.unmillenniumproject.org/goals/index.htm\">UN Millennium Development Goals</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1329\nCached time: 20180909000922\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.232 seconds\nReal time usage: 0.299 seconds\nPreprocessor visited node count: 1543/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 21847/2097152 bytes\nTemplate argument size: 726/2097152 bytes\nHighest expansion depth: 9/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 10348/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.094/10.000 seconds\nLua memory usage: 3.93 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  225.360      1 -total\n 37.38%   84.243      1 Template:Reflist\n 34.47%   77.683      1 Template:Infobox_organization\n 26.60%   59.952      1 Template:Infobox\n 25.02%   56.396      1 Template:Advert\n 19.21%   43.287      3 Template:Cite_web\n 15.65%   35.277      1 Template:Ambox\n 10.43%   23.511      6 Template:Cite_book\n  7.12%   16.048      2 Template:Unbulleted_list\n  3.90%    8.787      4 Template:If_empty\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:22613352-0!canonical and timestamp 20180909000921 and revision id 849068340\n -->\n</div>"},"langlinks":[{"lang":"ko","url":"https://ko.wikipedia.org/wiki/%EA%B5%AD%EC%A0%9C_%EB%B0%B1%EC%8B%A0_%EC%97%B0%EA%B5%AC%EC%86%8C","langname":"Korean","autonym":"\ud55c\uad6d\uc5b4","*":"\uad6d\uc81c \ubc31\uc2e0 \uc5f0\uad6c\uc18c"}],"categories":[{"sortkey":"","hidden":"","*":"CS1_errors:_dates"},{"sortkey":"","hidden":"","*":"Articles_with_a_promotional_tone_from_June_2018"},{"sortkey":"","hidden":"","*":"All_articles_with_a_promotional_tone"},{"sortkey":"","*":"Public_health_organizations"},{"sortkey":"","*":"World_Health_Organization"},{"sortkey":"","*":"United_Nations_Development_Programme"},{"sortkey":"","*":"Organizations_established_by_the_United_Nations"},{"sortkey":"","*":"Vaccination-related_organizations"},{"sortkey":"","*":"International_medical_and_health_organizations"},{"sortkey":"","*":"Global_health"},{"sortkey":"","*":"Intergovernmental_organizations_established_by_treaty"}],"links":[{"ns":14,"exists":"","*":"Category:Articles with a promotional tone from June 2018"},{"ns":0,"exists":"","*":"Aedes"},{"ns":0,"exists":"","*":"Animal model"},{"ns":0,"exists":"","*":"Asia-Pacific"},{"ns":0,"exists":"","*":"Bali"},{"ns":0,"exists":"","*":"Bangladesh"},{"ns":0,"exists":"","*":"Barry Bloom"},{"ns":0,"exists":"","*":"Beira, Mozambique"},{"ns":0,"exists":"","*":"Bhutan"},{"ns":0,"exists":"","*":"Bill & Melinda Gates Foundation"},{"ns":0,"exists":"","*":"Brazil"},{"ns":0,"exists":"","*":"Burkina Faso"},{"ns":0,"exists":"","*":"Cambodia"},{"ns":0,"exists":"","*":"Centers for Disease Control and Prevention"},{"ns":0,"exists":"","*":"China"},{"ns":0,"exists":"","*":"Cholera"},{"ns":0,"exists":"","*":"Cholera vaccine"},{"ns":0,"exists":"","*":"Colombia"},{"ns":0,"exists":"","*":"Conjugate vaccine"},{"ns":0,"exists":"","*":"Cote d'Ivoire"},{"ns":0,"exists":"","*":"Dengue fever"},{"ns":0,"exists":"","*":"Dengue vaccine"},{"ns":0,"exists":"","*":"Dhaka"},{"ns":0,"exists":"","*":"Ecuador"},{"ns":0,"exists":"","*":"Egypt"},{"ns":0,"exists":"","*":"Federal Ministry of Education and Research (Germany)"},{"ns":0,"exists":"","*":"Gabon"},{"ns":0,"exists":"","*":"Germany"},{"ns":0,"exists":"","*":"GlaxoSmithKline"},{"ns":0,"exists":"","*":"Guangxi"},{"ns":0,"exists":"","*":"HIV"},{"ns":0,"exists":"","*":"Headquarters of the United Nations"},{"ns":0,"exists":"","*":"Hebei"},{"ns":0,"exists":"","*":"Hechi"},{"ns":0,"exists":"","*":"Hong Soon-young"},{"ns":0,"exists":"","*":"Hu\u1ebf"},{"ns":0,"exists":"","*":"India"},{"ns":0,"exists":"","*":"Indonesia"},{"ns":0,"exists":"","*":"Instituto Butantan"},{"ns":0,"exists":"","*":"International organization"},{"ns":0,"exists":"","*":"Israel"},{"ns":0,"exists":"","*":"Jamaica"},{"ns":0,"exists":"","*":"Japanese Encephalitis"},{"ns":0,"exists":"","*":"Johns Hopkins University"},{"ns":0,"exists":"","*":"Karachi"},{"ns":0,"exists":"","*":"Kazakhstan"},{"ns":0,"exists":"","*":"Kenya"},{"ns":0,"exists":"","*":"Kh\u00e1nh H\u00f2a Province"},{"ns":0,"exists":"","*":"Kolkata"},{"ns":0,"exists":"","*":"Kuwait"},{"ns":0,"exists":"","*":"Kyrgyzstan"},{"ns":0,"exists":"","*":"Laos"},{"ns":0,"exists":"","*":"Lebanon"},{"ns":0,"exists":"","*":"Liberia"},{"ns":0,"exists":"","*":"Malaysia"},{"ns":0,"exists":"","*":"Malta"},{"ns":0,"exists":"","*":"Matlab (Bangladesh)"},{"ns":0,"exists":"","*":"Merck & Co."},{"ns":0,"exists":"","*":"Mexico"},{"ns":0,"exists":"","*":"Mongolia"},{"ns":0,"exists":"","*":"Mozambique"},{"ns":0,"exists":"","*":"Myanmar"},{"ns":0,"exists":"","*":"National Institutes of Health"},{"ns":0,"exists":"","*":"Nepal"},{"ns":0,"exists":"","*":"Netherlands"},{"ns":0,"exists":"","*":"Nha Trang"},{"ns":0,"exists":"","*":"Nicaragua"},{"ns":0,"exists":"","*":"North Jakarta"},{"ns":0,"exists":"","*":"Oman"},{"ns":0,"exists":"","*":"PATH (global health organization)"},{"ns":0,"exists":"","*":"Pakistan"},{"ns":0,"exists":"","*":"Panama"},{"ns":0,"exists":"","*":"Papua New Guinea"},{"ns":0,"exists":"","*":"Paratyphoid fever"},{"ns":0,"exists":"","*":"Peru"},{"ns":0,"exists":"","*":"Philippines"},{"ns":0,"exists":"","*":"Polysaccharide"},{"ns":0,"exists":"","*":"Republic of Korea"},{"ns":0,"exists":"","*":"Romania"},{"ns":0,"exists":"","*":"Rotavirus vaccine"},{"ns":0,"exists":"","*":"Sabin Vaccine Institute"},{"ns":0,"exists":"","*":"Samoo Architects & Engineers"},{"ns":0,"exists":"","*":"Sanofi"},{"ns":0,"exists":"","*":"Sanofi Pasteur"},{"ns":0,"exists":"","*":"Saraburi Province"},{"ns":0,"exists":"","*":"Senegal"},{"ns":0,"exists":"","*":"Seoul"},{"ns":0,"exists":"","*":"Seoul National University"},{"ns":0,"exists":"","*":"Shanchol"},{"ns":0,"exists":"","*":"Shigella"},{"ns":0,"exists":"","*":"Shigellosis"},{"ns":0,"exists":"","*":"Slovakia"},{"ns":0,"exists":"","*":"South Korea"},{"ns":0,"exists":"","*":"Spain"},{"ns":0,"exists":"","*":"Sri Lanka"},{"ns":0,"exists":"","*":"Sweden"},{"ns":0,"exists":"","*":"Tajikistan"},{"ns":0,"exists":"","*":"Thailand"},{"ns":0,"exists":"","*":"Treaty series"},{"ns":0,"exists":"","*":"Turkey"},{"ns":0,"exists":"","*":"Typhoid fever"},{"ns":0,"exists":"","*":"Typhoid vaccine"},{"ns":0,"exists":"","*":"United Arab Emirates"},{"ns":0,"exists":"","*":"United Nations Development Programme"},{"ns":0,"exists":"","*":"University of Gothenburg"},{"ns":0,"exists":"","*":"Uzbekistan"},{"ns":0,"exists":"","*":"Vaccination schedule"},{"ns":0,"exists":"","*":"Vaccines"},{"ns":0,"exists":"","*":"Vienna Convention on the Law of Treaties"},{"ns":0,"exists":"","*":"Vietnam"},{"ns":0,"exists":"","*":"World Health Organization"},{"ns":0,"exists":"","*":"World Health Organization (WHO)"},{"ns":4,"exists":"","*":"Wikipedia:External links"},{"ns":4,"exists":"","*":"Wikipedia:Neutral point of view"},{"ns":4,"exists":"","*":"Wikipedia:Spam"},{"ns":4,"exists":"","*":"Wikipedia:What Wikipedia is not"},{"ns":12,"exists":"","*":"Help:CS1 errors"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:Advert"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Infobox organization"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:If empty"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Comma separated entries"},{"ns":10,"exists":"","*":"Template:Longitem"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:If empty"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Separated entries"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"}],"images":["Ambox_important.svg","IVI_New_Logo_Big.jpg","Establishment_Agreement_Signing.jpg","IVI_Building_(1).jpg"],"externallinks":["https://www.crunchbase.com/person/seung-il-shin","https://treaties.un.org/Pages/ViewDetails.aspx?src=TREATY&mtdsg_no=IX-3&chapter=9&clang=_en","http://www.ivi.int/wp-content/uploads/kboard_attached/11/201610/IVI%20Annual%20Report%202015.pdf","http://www.ivi.int/about_us/signatory_countries.html","http://www.ivi.int/wp-content/uploads/2017/03/IVIAnnualReport2017_ENG.pdf","http://www.ivi.int/publication/IVI_Global_cholera_case.pdf","http://www.globe-network.org/documents/conferences/2009/Focus-on-neglected-tropical-infectious-diseases-Integrating-vaccines-into-global-cholera-control-efforts/Scientific-report.pdf","http://www.IVI.int","https://www.payette.com/","http://www.vabiotech.com.vn/?lang=en","http://nihe.org.vn/en/home-c10902.htm","http://www.denguevaccine.org/resource-search/?types%5B%5D=2","http://ivac.jhu.edu/","http://www.ivi.int/","http://www.denguevaccines.org","http://viva.ivi.int/","http://www.who.int/","http://www.biomedcentral.com/inst/124916","http://www.unmillenniumproject.org/goals/index.htm"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"International_Vaccine_Institute","byteoffset":2122,"anchor":"History"},{"toclevel":2,"level":"3","line":"Background","number":"1.1","index":"2","fromtitle":"International_Vaccine_Institute","byteoffset":2137,"anchor":"Background"},{"toclevel":2,"level":"3","line":"Foundation","number":"1.2","index":"3","fromtitle":"International_Vaccine_Institute","byteoffset":3327,"anchor":"Foundation"},{"toclevel":2,"level":"3","line":"Headquarters building","number":"1.3","index":"4","fromtitle":"International_Vaccine_Institute","byteoffset":5778,"anchor":"Headquarters_building"},{"toclevel":1,"level":"2","line":"Previous activities","number":"2","index":"5","fromtitle":"International_Vaccine_Institute","byteoffset":6443,"anchor":"Previous_activities"},{"toclevel":2,"level":"3","line":"Diseases of the Most Impoverished (DOMI) 2000-2006","number":"2.1","index":"6","fromtitle":"International_Vaccine_Institute","byteoffset":6470,"anchor":"Diseases_of_the_Most_Impoverished_(DOMI)_2000-2006"},{"toclevel":3,"level":"4","line":"DOMI typhoid","number":"2.1.1","index":"7","fromtitle":"International_Vaccine_Institute","byteoffset":7869,"anchor":"DOMI_typhoid"},{"toclevel":3,"level":"4","line":"DOMI cholera","number":"2.1.2","index":"8","fromtitle":"International_Vaccine_Institute","byteoffset":9347,"anchor":"DOMI_cholera"},{"toclevel":3,"level":"4","line":"DOMI shigellosis","number":"2.1.3","index":"9","fromtitle":"International_Vaccine_Institute","byteoffset":11070,"anchor":"DOMI_shigellosis"},{"toclevel":2,"level":"3","line":"Rotavirus Diarrhea Program 1999-2010","number":"2.2","index":"10","fromtitle":"International_Vaccine_Institute","byteoffset":12515,"anchor":"Rotavirus_Diarrhea_Program_1999-2010"},{"toclevel":2,"level":"3","line":"Dengue Vaccine Programs 2002-2016","number":"2.3","index":"11","fromtitle":"International_Vaccine_Institute","byteoffset":13718,"anchor":"Dengue_Vaccine_Programs_2002-2016"},{"toclevel":3,"level":"4","line":"The Pediatric Dengue Vaccine Initiative (PDVI<b>)</b>","number":"2.3.1","index":"12","fromtitle":"International_Vaccine_Institute","byteoffset":13761,"anchor":"The_Pediatric_Dengue_Vaccine_Initiative_(PDVI)"},{"toclevel":3,"level":"4","line":"Dengue Vaccine Initiative (DVI)","number":"2.3.2","index":"13","fromtitle":"International_Vaccine_Institute","byteoffset":15627,"anchor":"Dengue_Vaccine_Initiative_(DVI)"},{"toclevel":2,"level":"3","line":"Signatory Countries of the IVI","number":"2.4","index":"14","fromtitle":"International_Vaccine_Institute","byteoffset":17500,"anchor":"Signatory_Countries_of_the_IVI"},{"toclevel":1,"level":"2","line":"Achievements","number":"3","index":"15","fromtitle":"International_Vaccine_Institute","byteoffset":19327,"anchor":"Achievements"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"16","fromtitle":"International_Vaccine_Institute","byteoffset":21185,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"5","index":"17","fromtitle":"International_Vaccine_Institute","byteoffset":21213,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"International Vaccine Institute","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q6054186"}]}}